Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
This guide walks through factors to consider when choosing between BTC and ETH for a first purchase, including risk tolerance and goals.
27,350 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
The stock market has surged on earnings and AI investments, but key policy and geopolitical risks loom. This guide ex...
An insider move of 8,000 shares can raise questions for investors. This article breaks down what such a sale might si...
OpenAI reportedly considers delaying its IPO, placing AI stocks in the spotlight. This guide breaks down the potentia...
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
July brought a surprising bounce in the stock market as a major theater chain beat earnings expectations and drew att...
Could Palantir’s stock be meaningfully higher by 2027? This article offers a grounded forecast with base, bull, and b...
As AI demand climbs, power reliability becomes the bottleneck. This energy stock helping power AI offers a way to inv...
The Middle East crisis is sending shockwaves through the stock market, but airlines are taking the biggest hit. This ...
Want the most cash back without paying an annual fee? This comparison chart of no annual fee cashback cards breaks do...
This article breaks down DigitalOcean's hypothetical 2025 earnings transcript to help investors gauge growth quality,...